Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study

Recruiting N/A Interventional Study
ADHD
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 16
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
40 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of the MiA-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Through the use of the Mio-Training, cognitive development will be strengthened and metacognitive thinking and awareness will increase. The MiA-Study is conducted additionally to…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Informed consent as documented by signature (see Informed Consent Form) of participants and / or one parent / legal guardian * Age 8-16 years * A diagnosis of ADHD (mild, moderate or severe) * Intelligence \>85 (WISC-V short form) * German or french speaking * Willingness to p…
Contacts

Regula Everts, Prof. Dr. phil.

+41 31 632 84 97

regula.everts@insel.ch

CONTACT

Saskia Salzmann, MSc

+41 31 664 59 84

saskia.salzmann@insel.ch

CONTACT